“`html
The black mamba ranks among the most lethal venomous serpents worldwide.(Image credit: reptiles4all/Getty Images)ShareShare by:
- Copy link
- X
Share this article 0Join the conversationFollow usAdd us as a preferred source on GoogleNewsletterSubscribe to our newsletter
Indications of mamba envenomation occasionally worsen in those treated with antivenin — and investigators might at last understand why.
The intricate interaction between poisons and antivenin within the organism reveals concealed neurological signs originating from particular toxins in the venom. These veiled symptoms manifest once the consequences of other, similarly hazardous toxins are counteracted.
You may like
-
New antivenom works against 17 dangerous African snake species, study suggests
-
Venomous snake strikes captured in extreme detail through high-speed videos for first time
-
Lab monkeys on the loose in Mississippi don’t have herpes, university says. But are they dangerous?
There exist four varieties of mamba snakes, categorized under the genus Dendroaspis. Mamba bites constitute critical medical situations in sub-Saharan Africa, notably those from the black mamba, deemed among the planet’s most dangerous snakes as its bite proves invariably fatal absent prompt treatment.
Absent swift action, the neurotoxins present in mamba venom may induce demise via respiratory failure and heart attack within an hour, playing a role in the over 30,000 snakebite-related deaths within the region each year.
Mamba toxins target the neurological system, largely by “hacking” nerve receptors situated on muscles, as explained to Live Science by study co-author Brian Fry, a molecular biologist affiliated with the University of Queensland. This action impedes nerve impulses originating from the brain from reaching the muscles.
“You wouldn’t even be aware that this is happening until you attempted to perform something, such as walking or breathing,” Fry stated. This impact — defined by the inability of muscles to contract — is identified as limp or flaccid paralysis, against which existing antivenins demonstrate efficacy. This type of paralysis is initiated by the venoms of three of the four mamba varieties: the western green, Jameson’s mamba, and black mamba.
However, mamba venoms operate in a second capacity, yielding the opposite outcome: it floods the muscle with neural signals, thereby inciting uncontrollable spasms. This phenomenon is referred to as rigid or spastic paralysis. “Instead of being unable to breathe due to their diaphragm being completely limp, [now the patient] cannot breathe because their diaphragm is completely contracted,” Fry elucidated.
In the past, scientists posited that the neurotoxins accountable for rigid paralysis were uniquely found within the fourth variety, the eastern green mamba venom. Venoms from the other three mambas were presumed to solely induce limp paralysis. “What was unknown is that [rigid paralysis] has consistently been occurring in the background with the other varieties as well,” Fry noted.
Fry and his team scrutinized how venoms from the four mamba varieties assail the neurological system, alongside assessing the effectiveness of three antivenins commercially accessible in Africa in mitigating these effects. They executed these analyses utilizing neuromuscular tissue obtained from lab animals, enabling them to chemically or electrically rouse a segment of muscle. Introduction of eastern green mamba venom prompted spasms within the tissue, whereas venoms from the remaining mambas elicited no discernible reaction — specifically, until they endeavored to activate the muscle and encountered no response due to the venoms preventing muscle contraction.
You may like
-
New antivenom works against 17 dangerous African snake species, study suggests
-
Venomous snake strikes captured in extreme detail through high-speed videos for first time
-
Lab monkeys on the loose in Mississippi don’t have herpes, university says. But are they dangerous?
The three antivenins effectively addressed the limp-paralysis impacts spanning all mamba varieties, restoring the muscles’ ability to contract. Nevertheless, at that juncture, rigid paralysis manifested in specific scenarios, against which the antivenins demonstrated limited efficacy. In individuals bitten by mambas, “spastic paralysis can prove fatal; however, flaccid paralysis poses a greater threat due to its typically more potent nature,” Fry pointed out.
The researchers additionally observed that the venom of the black mamba — capable of inducing fatality with a mere couple of droplets — exhibited variability among snakes originating from Kenya and South Africa. The venoms differed both in their influence on tissue and their responsiveness to antivenins.
RELATED STORIES
—Scientists could soon create a ‘universal antivenom.’ But would it save lives?
—Cobra venom kills by collapsing blood vessels, organ-on-a-chip shows
—32 of the most venomous animals in the world
“Understanding geographic venom diversification is essential for formulating antivenins that incorporate antibodies capable of countering all clinically relevant poisons from a variety of species, irrespective of their geographic origin,” Andreas Hougaard Laustsen-Kiel, a biotechnologist from the Technical University of Denmark who was not involved in the study, conveyed to Live Science via email. “The study’s significance resides in its demonstration that antivenins must undergo optimization to neutralize both poison types to attain effectiveness.”
Fry intends to undertake a more thorough and expansive examination of the black mamba in the future.
“We aim to more precisely delineate which antivenin exhibits superior performance within a specific region,” he mentioned, “furnishing physicians with the sort of data that assumes criticality for evidence-based crafting of clinical management protocols.”
Disclaimer
This article serves exclusively for informational purposes and does not intend to provide medical advice.
Payal DharLive Science Contributor
Payal Dhar (she/they) functions as a freelance journalist, producing content pertaining to science, technology, and societal matters. Their focus encompasses AI, engineering, materials science, cybersecurity, space, gaming, digital communities, and any novel technology that piques their curiosity. She has contributed to Science News, Scientific American, Nature, Washington Post, Guardian, Chemical & Engineering News, IEEE Spectrum, amongst others. Additionally, they engage in writing science-fiction and fantasy works. Individuals can follow her @payaldhar.bluesky.social or explore her creations at payaldhar.contently.com.
Show More Comments
You must confirm your public display name before commenting
Please logout and then login again, you will then be prompted to enter your display name.
LogoutRead more
New antivenom works against 17 dangerous African snake species, study suggests
Venomous snake strikes captured in extreme detail through high-speed videos for first time
Lab monkeys on the loose in Mississippi don’t have herpes, university says. But are they dangerous?
A fentanyl vaccine enters human trials in 2026 — here’s how it works
A ‘functional cure’ for HIV may be in reach, early trials suggest
Man caught rabies from organ transplant after donor was scratched by skunk
Latest in Medicine & Drugs
US government overhauls the childhood vaccine schedule in unprecedented move
New drug could prevent diabetes complications not fixed with blood sugar control, study hints